Nanjing King-friend Biochemical Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 10.45%

Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has an Asset Resilience Ratio of 10.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Nanjing King-friend Biochemical Pharmace (603707) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.12 Billion

≈ $163.47 Million USD Cash + Short-term Investments

Total Assets

CN¥10.69 Billion

≈ $1.56 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Nanjing King-friend Biochemical Pharmace defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets Composition Over Time

This chart breaks down Nanjing King-friend Biochemical Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Nanjing King-friend Biochemical Pharmace.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.12 Billion	10.45%
Total Liquid Assets	CN¥1.12 Billion	10.45%

Asset Resilience Insights

Moderate Liquidity: Nanjing King-friend Biochemical Pharmaceutical Co Ltd has 10.45% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Krka d. d WAR:KRK	Drug Manufacturers - Specialty & Generic	11.18%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Jilin Aodong Pharmaceutical Group Co Ltd SHE:000623	Drug Manufacturers - Specialty & Generic	4.97%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Guangdong Taienkang Pharmaceutical Co. Ltd SHE:301263	Drug Manufacturers - Specialty & Generic	6.08%
Tianjin Ringpu Bio Tech SHE:300119	Drug Manufacturers - Specialty & Generic	14.27%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	12.73%	CN¥1.32 Billion ≈ $192.65 Million	CN¥10.34 Billion ≈ $1.51 Billion	+1.63pp
2024-12-31	11.10%	CN¥1.06 Billion ≈ $154.44 Million	CN¥9.51 Billion ≈ $1.39 Billion	+3.94pp
2023-12-31	7.16%	CN¥681.99 Million ≈ $99.80 Million	CN¥9.52 Billion ≈ $1.39 Billion	+7.15pp
2022-12-31	0.01%	CN¥1.30 Million ≈ $190.23K	CN¥10.01 Billion ≈ $1.46 Billion	-3.15pp
2021-12-31	3.16%	CN¥259.80 Million ≈ $38.02 Million	CN¥8.22 Billion ≈ $1.20 Billion	-7.79pp
2020-12-31	10.96%	CN¥845.79 Million ≈ $123.77 Million	CN¥7.72 Billion ≈ $1.13 Billion	+9.84pp
2019-12-31	1.12%	CN¥56.64 Million ≈ $8.29 Million	CN¥5.08 Billion ≈ $743.13 Million	-18.18pp
2017-12-31	19.30%	CN¥520.00 Million ≈ $76.09 Million	CN¥2.69 Billion ≈ $394.33 Million	+5.42pp
2015-12-31	13.87%	CN¥180.00 Million ≈ $26.34 Million	CN¥1.30 Billion ≈ $189.85 Million	+13.77pp
2014-12-31	0.11%	CN¥1.64 Million ≈ $239.56K	CN¥1.54 Billion ≈ $225.37 Million	--

pp = percentage points

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SHG:603707 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.93 Billion

CN¥13.18 Billion CNY

Market Cap Rank

#6306 Global

#1267 in China

Share Price

CN¥8.16

Change (1 day)

+0.74%

52-Week Range

CN¥6.84 - CN¥11.76

All Time High

CN¥33.62